市場調査レポート

商品コード

1765475

合成生物学（シンバイオ）の世界市場（2026年～2036年）

The Global Synthetic Biology (SynBio) Market 2026-2036

出版日: 2025年07月09日
発行: Future Markets, Inc.
ページ情報: 英文 480 Pages, 133 Tables, 70 Figures
納期: 即納可能

価格

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の合成生物学市場は、現代のバイオテクノロジーにおいてもっとも変革的な急速に拡大している部門の1つであり、医療、農業、製造、環境問題への取り組み方を根本的に変えています。2024年の市場規模は約160億～180億米ドルで、遺伝子工学、コンピューターによる設計、自動化された生物学的システムの進歩による爆発的な成長が予測されています。

合成生物学市場は、CAGRで20.6～28.63%の力強い成長を示しており、複数の要因の収束によって促進されています。DNAシーケンシングおよびDNA合成のコストが劇的に低下したことで、遺伝子工学ツールへのアクセスが民主化され、AIと機械学習アルゴリズムが生物学的システムの設計を加速しています。バイオベースの製品に対する需要の伸びや、個別化治療に対する需要の増加、DNAシーケンシングおよびDNA合成技術の進歩は、市場成長の主な促進要因です。

製薬・医療部門が市場情勢で優位に立っています。この優位性は、合成生物学が創薬、個別化医療、治療法開発に与える影響に起因します。この技術により、従来は治療不可能であった病気に対処する新しい生物製剤、合成ワクチン、人工細胞療法の創出が可能になります。

著しい成長が見込まれる一方で、合成生物学市場は複数の課題に直面しています。既存の枠組みが急速な技術の進歩に追いつくのに苦労しているため、規制の不確実性が依然として大きな障壁となっています。遺伝子工学の応用を取り巻く社会的受容と倫理的懸念には、継続的な注意と、利益とリスクに関する透明性のあるコミュニケーションが必要です。技術的課題としては、実験室での技術革新を工業生産に拡大すること、操作された生物学的システムの信頼性と予測可能性を確保すること、標準化されたツールと方法論を開発することなどが挙げられます。生物学的システムの複雑性は、持続的な研究開発投資を必要とする工学の課題を提示し続けています。

合成生物学市場は、プログラマブル生物学へのパラダイムシフトを示しており、人工生物学的システムは、医療、食料安全保障、気候変動、持続可能な製造といった世界的課題に対処します。技術が成熟し、コストが低下し続ける中、合成生物学は21世紀のバイオエコノミーの礎石となり、人類の喫緊の課題に取り組むと同時に、イノベーションと経済成長のかつてない機会を創出することになるとみられます。

当レポートでは、世界の合成生物学（シンバイオ）市場について調査分析し、医薬品、農業、産業用バイオテクノロジー、環境ソリューションを含む主な応用分野における、市場力学、技術革新、競合ポジショニング、成長機会などに関する知見を提供しています。

市場の動向と促進要因
産業の課題と抑制要因
バイオエコノミーにおける合成生物学
SWOT分析
合成生物学市場
- バイオ燃料
- バイオベース化学品
- バイオプラスチック、バイオポリマー
- バイオレメディエーション
- 生体触媒
- 食品、栄養補助食品成分
- 持続可能な農業
- テキスタイル
- 包装
- 医療、医薬品
- 化粧品
- 界面活性剤、洗剤
- 建材
世界市場の収益（2018年～2036年）
- 技術別
- 製品タイプ別
- 市場別
- 地域別
将来の市場見通し

第5章企業プロファイル（企業321社のプロファイル）

第6章付録

第7章参考文献

図表

List of Tables

Table 1. Comparison of synthetic biology and genetic engineering
Table 2. Global Revenues for Synthetic Biology by Technology, 2018-2036 (Billion USD)
Table 3. Global Revenues for Synthetic Biology by Product Type, 2018-2036 (Billion USD)
Table 4. Global revenues for synthetic biology, by market, 2018-2036 (Billion USD)
Table 5. Global revenues for synthetic biology, by region, 2018-2036 (Billion USD)
Table 6. Major trends and drivers in synthetic biology
Table 7. Investments in synthetic biology
Table 8. Phase 1: Foundation & Optimization (2025-2027)
Table 9. Phase 2: Integration & Scale (2028-2030)
Table 10. Phase 3: Transformation & Convergence (2031-2033)
Table 11. Phase 4: Maturation & Optimization (2034-2036)
Table 12. Differences between synthetic biology and conventional processes
Table 13. Main application areas for synthetic biology
Table 14. Advantages of synthetic biology
Table 15. Key biomanufacturing processes utilized in synthetic biology
Table 16. Molecules produced through industrial biomanufacturing
Table 17. Continuous vs batch biomanufacturing
Table 18. Key fermentation parameters in batch vs continuous biomanufacturing processes
Table 19. Synthetic biology fermentation processes
Table 20. Cell-free versus cell-based systems
Table 21. Comparison of the biomanufacturing processes in synthetic biology
Table 22. Major microbial cell factories used in industrial biomanufacturing
Table 23. Core stages - Design, Build and Test
Table 24. Key tools and techniques used in metabolic engineering for pathway optimization
Table 25. Key applications of metabolic engineering
Table 26. Main DNA synthesis technologies
Table 27. Main gene assembly methods
Table 28. Key applications of genome engineering
Table 29. Engineered proteins in industrial applications
Table 30.Key computational tools and their applications in synthetic biology
Table 31. Feedstocks for synthetic biology
Table 32. Products from C1 feedstocks in white biotechnology
Table 33. C2 Feedstock Products
Table 34. CO2 derived products via biological conversion-applications, advantages and disadvantages
Table 35. Production capacities of biorefinery lignin producers
Table 36. Common starch sources that can be used as feedstocks for producing biochemicals
Table 37. Biomass processes summary, process description and TRL
Table 38. Pathways for hydrogen production from biomass
Table 39. Overview of alginate-description, properties, application and market size
Table 40. Blue biotechnology companies
Table 41. Market trends and drivers in synthetic biology
Table 42. Industry challenges and restraints in synthetic biology
Table 43. Key markets and applications for synthetic biology
Table 44. Comparison of biofuels
Table 45. Categories and examples of solid biofuel
Table 46. Comparison of biofuels and e-fuels to fossil and electricity
Table 47. Classification of biomass feedstock
Table 48. Biorefinery feedstocks
Table 49. Feedstock conversion pathways
Table 50. First-Generation Feedstocks
Table 51. Lignocellulosic ethanol plants and capacities
Table 52. Comparison of pulping and biorefinery lignins
Table 53. Commercial and pre-commercial biorefinery lignin production facilities and processes
Table 54. Operating and planned lignocellulosic biorefineries and industrial flue gas-to-ethanol
Table 55. Properties of microalgae and macroalgae
Table 56. Yield of algae and other biodiesel crops
Table 57. Processes in bioethanol production
Table 58. Microorganisms used in CBP for ethanol production from biomass lignocellulosic
Table 59. Biodiesel by generation
Table 60. Biodiesel production techniques
Table 61. Biofuel production cost from the biomass pyrolysis process
Table 62. Biogas feedstocks
Table 63. Advantages and disadvantages of Bio-aviation fuel
Table 64. Production pathways for Bio-aviation fuel
Table 65. Current and announced Bio-aviation fuel facilities and capacities
Table 66. Algae-derived biofuel producers
Table 67. Markets and applications for biohydrogen
Table 68. Comparison of different Bio-H2 production pathways
Table 69. Properties of petrol and biobutanol
Table 70. Comparison of biogas, biomethane and natural gas
Table 71. Biobased chemicals that can be produced using synthetic biology approaches
Table 72. Applications of bio-based caprolactam
Table 73. Applications of bio-based acrylic acid
Table 74. Applications of bio-based 1,4-Butanediol (BDO)
Table 75. Applications of bio-based ethylene
Table 76. Biobased feedstock sources for 3-HP
Table 77. Applications of 3-HP
Table 78. Applications of bio-based 1,3-Propanediol (1,3-PDO)
Table 79. Biobased feedstock sources for itaconic acid
Table 80. Applications of bio-based itaconic acid
Table 81. Biobased feedstocks that can be used to produce 1,5-diaminopentane (DA5)
Table 82. Applications of DN5
Table 83. Applications of bio-based Tetrahydrofuran (THF)
Table 84. Markets and applications for malonic acid
Table 85. Biobased feedstock sources for MEG
Table 86. Applications of bio-based MEG
Table 87. Applications of bio-based propylene
Table 88. Biobased feedstock sources for Succinic acid
Table 89. Applications of succinic acid
Table 90. Bioplastics and bioplastic precursors synthesized via white biotechnology processes
Table 91. Polylactic acid (PLA) market analysis-manufacture, advantages, disadvantages and applications
Table 92. PLA producers and production capacities
Table 93.Types of PHAs and properties
Table 94. Comparison of the physical properties of different PHAs with conventional petroleum-based polymers
Table 95. Polyhydroxyalkanoate (PHA) extraction methods
Table 96. Commercially available PHAs
Table 97. Types of protein based-bioplastics, applications and companies
Table 98. Applications of white biotechnology in bioremediation and environmental remediation
Table 99. Companies developing fermentation-derived food
Table 100. Biofertilizer companies
Table 101. Biopesticides companies
Table 102. Biostimulants companies
Table 103. Crop biotechnology companies
Table 104. Types of sustainable alternative leathers
Table 105. Properties of bio-based leathers
Table 106. Comparison with conventional leathers
Table 107. Price of commercially available sustainable alternative leather products
Table 108. Comparative analysis of sustainable alternative leathers
Table 109. Key processing steps involved in transforming plant fibers into leather materials
Table 110. Current and emerging plant-based leather products
Table 111. Companies developing plant-based leather products
Table 112. Overview of mycelium-description, properties, drawbacks and applications
Table 113. Companies developing mycelium-based leather products
Table 114. Types of microbial-derived leather alternative
Table 115. Companies developing microbial leather products
Table 116. Companies developing plant-based leather products
Table 117. Types of protein-based leather alternatives
Table 118. Companies developing protein based leather
Table 119. Applications, advantages and disadvantages of PHAs in packaging
Table 120. Types of protein based-bioplastics, applications and companies
Table 121. Overview of alginate-description, properties, application and market size
Table 122. Pharmaceutical applications of synthetic biology
Table 123. companies involved in synthetic biology for gene therapy and regenerative medicine
Table 124. Companies involved in synthetic biology for vaccine production
Table 125. Companies involved in synthetic biology for personalized medicine
Table 126. Synthetic biology companies in healthcare and pharmaceuticals
Table 127. Applications of biotechnology in the cosmetics industry
Table 128. Sustainable biomanufacturing of surfactants and detergents
Table 129. Global Revenues for Synthetic Biology by Technology, 2018-2036 (Billion USD)
Table 130. Global Revenues for Synthetic Biology by Product Type, 2018-2036 (Billion USD)
Table 131. Global revenues for synthetic biology, by market, 2018-2036 (Billion USD)
Table 132. Global revenues for synthetic biology, by region, 2018-2036 (Billion USD)
Table 133. Glossary of Terms

List of Figures

Figure 1. Global Revenues for Synthetic Biology by Technology, 2018-2036 (Billion USD)
Figure 2. Global Revenues for Synthetic Biology by Product Type, 2018-2036 (Billion USD)
Figure 3. Global revenues for synthetic biology, by market, 2018-2036 (Billion USD)
Figure 4. Global revenues for synthetic biology, by region, 2018-2036 (Billion USD)
Figure 6. Industrial biotechnology value chain
Figure 7. Cell-free and cell-based protein synthesis systems
Figure 8. CRISPR/Cas9 & Targeted Genome Editing
Figure 9. Genetic Circuit-Assisted Smart Microbial Engineering
Figure 10. Microbial Chassis Development for Natural Product Biosynthesis
Figure 11. LanzaTech gas-fermentation process
Figure 12. Schematic of biological CO2 conversion into e-fuels
Figure 13. Overview of biogas utilization
Figure 14. Biogas and biomethane pathways
Figure 15. Schematic overview of anaerobic digestion process for biomethane production
Figure 16. BLOOM masterbatch from Algix
Figure 17. SWOT analysis: synthetic biology
Figure 18. Schematic of a biorefinery for production of carriers and chemicals
Figure 19. Range of biomass cost by feedstock type
Figure 20. Overview of biogas utilization
Figure 21. Biogas and biomethane pathways
Figure 22. Schematic overview of anaerobic digestion process for biomethane production
Figure 23. Algal biomass conversion process for biofuel production
Figure 24. Pathways for algal biomass conversion to biofuels
Figure 25. Biobutanol production route
Figure 26. Renewable Methanol Production Processes from Different Feedstocks
Figure 27. Production of biomethane through anaerobic digestion and upgrading
Figure 28. Production of biomethane through biomass gasification and methanation
Figure 29. Production of biomethane through the Power to methane process
Figure 30. Overview of Toray process
Figure 31. Bacterial nanocellulose shapes
Figure 32. PHA family
Figure 33. AlgiKicks sneaker, made with the Algiknit biopolymer gel
Figure 34. Conceptual landscape of next-gen leather materials
Figure 35. Hermes bag made of MycoWorks' mycelium leather
Figure 36. Ganni blazer made from bacterial cellulose
Figure 37. Bou Bag by GANNI and Modern Synthesis
Figure 38. Paper cups lined with home-compostable PHA
Figure 39. Amorphous PHA Cosmetics Jar
Figure 40. Types of bio-based materials used for antimicrobial food packaging application
Figure 41. Self-healing bacteria crack filler for concrete
Figure 42. BioMason cement
Figure 43. Microalgae based biocement masonry bloc
Figure 44. Typical structure of mycelium-based foam
Figure 45. Commercial mycelium composite construction materials
Figure 46. Global Revenues for Synthetic Biology by Technology, 2018-2036 (Billion USD)
Figure 47. Global Revenues for Synthetic Biology by Product Type, 2018-2036 (Billion USD)
Figure 48. Global revenues for synthetic biology, by market, 2018-2036 (Billion USD)
Figure 49. Global revenues for synthetic biology, by region, 2018-2036 (Billion USD)
Figure 50. Jelly-like seaweed-based nanocellulose hydrogel
Figure 51. Algiknit yarn
Figure 52. ALGIECEL PhotoBioReactor
Figure 53. BIOLO e-commerce mailer bag made from PHA
Figure 54. Domsjo process
Figure 55. Mushroom leather
Figure 56. PHA production process
Figure 57. Light Bio Bioluminescent plants
Figure 58. Lignin gel
Figure 59. BioFlex process
Figure 60. TransLeather
Figure 61. Reishi
Figure 62. Compostable water pod
Figure 63. Precision Photosynthesis(TM) technology
Figure 64. Enfinity cellulosic ethanol technology process
Figure 65. Fabric consisting of 70 per cent wool and 30 per cent Qmilk
Figure 66. Lyocell process
Figure 67. Spider silk production
Figure 68. Corbion FDCA production process
Figure 69. UPM biorefinery process
Figure 70. The Proesa-R Process

The global synthetic biology market represents one of the most transformative and rapidly expanding sectors in modern biotechnology, fundamentally reshaping how we approach medicine, agriculture, manufacturing, and environmental challenges. Valued at approximately $16-18 billion in 2024, the market is projected to experience explosive growth, driven by advances in genetic engineering, computational design, and automated biological systems.

The synthetic biology market is experiencing robust growth at a compound annual growth rate (CAGR) of 20.6-28.63%, fueled by several converging factors. The dramatic reduction in DNA sequencing and synthesis costs has democratized access to genetic engineering tools, while artificial intelligence and machine learning algorithms have accelerated the design of biological systems. Rising demand for bio-based products, growing demand for personalized therapies, and advancements in DNA sequencing and synthesis technologies are key factors accelerating market growth.

The pharmaceutical and healthcare sector dominates the market landscape. This dominance stems from synthetic biology's impact on drug discovery, personalized medicine, and therapeutic development. The technology enables the creation of novel biologics, synthetic vaccines, and engineered cell therapies that address previously untreatable conditions.

Despite remarkable growth prospects, the synthetic biology market faces several challenges. Regulatory uncertainty remains a significant barrier, as existing frameworks struggle to keep pace with rapid technological advancement. Public acceptance and ethical concerns surrounding genetic engineering applications require ongoing attention and transparent communication about benefits and risks. Technical challenges include scaling laboratory innovations to industrial production, ensuring reliability and predictability of engineered biological systems, and developing standardized tools and methodologies. The complexity of biological systems continues to present engineering challenges that require sustained research and development investment.

The synthetic biology market represents a paradigm shift toward programmable biology, where engineered biological systems address global challenges in healthcare, food security, climate change, and sustainable manufacturing. As the technology matures and costs continue to decline, synthetic biology is poised to become a cornerstone of the 21st-century bioeconomy, creating unprecedented opportunities for innovation and economic growth while addressing humanity's most pressing challenges.

"The Global Synthetic Biology (Synbio) Market 2026-2036" represents the most comprehensive analysis of one of biotechnology's fastest-growing sectors, providing essential intelligence for investors, industry leaders, and strategic planners. This definitive market report delivers critical insights into the transformative synthetic biology landscape, covering market dynamics, technological innovations, competitive positioning, and growth opportunities across key application areas including pharmaceuticals, agriculture, industrial biotechnology, and environmental solutions.

Report contents include:

Technology-based revenue projections
Product type market dynamics (oligonucleotides, enzymes, synthetic genes, synthetic cells)
Regional market opportunities across North America, Europe, Asia-Pacific, and emerging markets
Application-specific growth drivers spanning 13 major industry verticals
Advanced biomanufacturing analysis encompasses:
- Batch versus continuous bioprocessing optimization
- Cell-free synthesis systems and scalability challenges
- Fermentation process innovations and efficiency improvements
- Biofilm-based production and microfluidic manufacturing systems
- Photobioreactor technologies and membrane bioreactor applications
Markets & Applications:
- Biofuels & Energy: Bioethanol, biodiesel, biogas, renewable diesel, biojet fuel, and hydrogen production
- Bio-based Chemicals: Industrial chemicals, specialty chemicals, and sustainable chemical manufacturing
- Bioplastics & Biopolymers: PLA, PHA, bio-PET, and next-generation biodegradable materials
- Healthcare & Pharmaceuticals: Drug discovery, gene therapy, vaccine production, personalized medicine
- Agriculture & Food: Crop enhancement, biofertilizers, biopesticides, alternative proteins
- Textiles & Materials: Bio-based fibers, sustainable leather alternatives, mycelium materials
- Environmental Solutions: Bioremediation, carbon capture, pollution control technologies
Regional Market Analysis & Growth Opportunities
Competitive Landscape & Company Profiles. The report features comprehensive profiles of 320+ leading synthetic biology companies, providing detailed analysis of business models, product portfolios, financial performance, and strategic positioning. Our competitive intelligence covers established biotechnology leaders, emerging startups, and technology platform providers across the synthetic biology value chain. Companies profiled include Aanika Biosciences, Aemetis Inc., AEP Polymers, Afyren, AgBiome, AgriSea NZ Seaweed Ltd, Agrivida, Ainnocence, AIO, AI Proteins, Algal Bio Co. Ltd., Algenol, AlgiKnit, Algiecel ApS, Alpha Biofuels Singapore Pte Ltd, Allonnia LLC, Allozymes, Alt.Leather, Alto Neuroscience, Amano Enzyme Inc., AmphiStar, Amply Discovery, AMSilk GmbH, Amyris, Andes Ag Inc., Ansa Biotechnologies, Antheia, Apeel Sciences, Aralez Bio, Arctic Biomaterials Oy, Ardra Bio, Arkeon, Arsenale Bioyards, Arzeda, Asimov, Atantares, Autolus, AVA Biochem AG, Avantium B.V., Azolla, Axcelon Biopolymers Corporation, Basecamp Research, BBCA Biochemical & GALACTIC Lactic Acid Co. Ltd., Benefuel Inc., BioBetter, Bioextrax AB, Bio Fab NZ, Biokemik, BIOLO, Biomason Inc., Biomemory, Bioplastech Ltd, BioSmart Nano, Biotic Circular Technologies Ltd., Biosyntia, Biotecam, Bioweg, bit.bio, Bloom Biorenewables SA, BluCon Biotech GmbH, Blue BioFuels Inc., Bluepha Beijing Lanjing Microbiology Technology Co. Ltd., Bon Vivant, Bolt Threads, Bosk Bioproducts Inc., Bowil Biotech Sp. z o.o., Braskem SA, Brightseed, Bucha Bio Inc., C1 Green Chemicals AG, C16 Biosciences, CABIO Biotech Wuhan Co Ltd, California Cultured, Calysta, Camena Bioscience, Capra Biosciences, Carbios, Cargill, Calyxt, Cascade Biocatalysts, Cass Materials Pty Ltd, Catalyxx, Cathy Biotech Inc., Cauldron Ferm, Cemvita Factory Inc., ChainCraft, Checkerspot, Chitose Bio Evolution Pte Ltd., CinderBio, Circe, CJ Biomaterials Inc., Clean Food Group, Codagenix, Codexis, Colossal Biosciences, Colipi, Colorifix, Conagen, Constructive Bio, Cysbio, Danimer Scientific, Debut Biotechnology, Deep Branch Biotechnology, Demetrix, Dispersa, DMC Biotechnologies, DNA Script, Domsjo Fabriker AB, DoriNano, DuPont, Earli, Ecovative Design LLC, Eco Fuel Technology Inc, Eden Brew, EggPlant Srl, Eligo Bioscience, Elo Life Systems, Emerging Fuels Technology EFT, Enduro Genetics, EnginZyme AB, Eni S.p.A., EnPlusOne Biosciences, Enzymaster, Enzymit, Erebagen, Esphera SynBio, Euglena Co. Ltd., Eversyn, Evozyne, FabricNano, Fermentalg, eniferBio, ENOUGH, Epoch Biodesign, Evolved By Nature, Evonetix Limited, Evonik Industries AG, EV Biotech, Farmless, Fermelanta and more......
Investment Analysis & Market Forecasts: insights into funding trends, valuation metrics, and growth opportunities across synthetic biology segments. The report examines venture capital flows, public market performance, and strategic acquisition activity, delivering essential intelligence for investment decision-making.
Market sizing and growth projections through 2036
Technology readiness levels and commercialization timelines
Risk assessment and regulatory consideration
Strategic partnership opportunities and M&A activity
Technology Roadmap & Future Outlook
Future market outlook:
- Emerging applications in space biotechnology and climate engineering
- Convergence with artificial intelligence and nanotechnology
- Regulatory evolution and standardization frameworks
- Global market expansion and democratization trends

This essential market intelligence report serves as the definitive guide for understanding synthetic biology's transformative potential, providing actionable insights for strategic planning, investment decisions, and market positioning in one of biotechnology's most dynamic sectors.

1. EXECUTIVE SUMMARY

1.1. Overview of the global synthetic biology market
1.2. Difference between synthetic biology and genetic engineering
1.3. Market size and growth projections
- 1.3.1. By Technology
- 1.3.2. By Product Type
- 1.3.3. By Market
- 1.3.4. By Region
1.4. Major trends and drivers
1.5. Investments in synthetic biology
1.6. Technology roadmap
1.7. Industrial biotechnology value chain

2. INTRODUCTION

2.1. What is synthetic biology?
2.2. Comparison with conventional processes
2.3. Applications
2.4. Advantages
2.5. Sustainability
2.6. Synthetic Biology for the Circular Economy

3. TECHNOLOGY ANALYSIS

3.1. Biomanufacturing processes
- 3.1.1. Batch biomanufacturing
- 3.1.2. Continuous biomanufacturing
- 3.1.3. Fermentation Processes
- 3.1.4. Cell-free synthesis
- 3.1.5. Biofilm-based production
- 3.1.6. Microfluidic systems
- 3.1.7. Photobioreactors
- 3.1.8. Membrane bioreactors
- 3.1.9. Plant cell culture
- 3.1.10. Mammalian cell culture
- 3.1.11. Bioprinting
3.2. Cell factories for biomanufacturing
3.3. Technology Overview
- 3.3.1. Metabolic engineering
- 3.3.2. Gene and DNA synthesis
- 3.3.3. Gene Synthesis and Assembly
- 3.3.4. Genome engineering
  - 3.3.4.1. CRISPR
    - 3.3.4.1.1. CRISPR/Cas9-modified biosynthetic pathways
    - 3.3.4.1.2. TALENs
    - 3.3.4.1.3. ZFNs
- 3.3.5. Protein/Enzyme Engineering
- 3.3.6. Synthetic genomics
  - 3.3.6.1. Principles of Synthetic Genomics
  - 3.3.6.2. Synthetic Chromosomes and Genomes
- 3.3.7. Strain construction and optimization
- 3.3.8. Smart bioprocessing
- 3.3.9. Chassis organisms
- 3.3.10. Biomimetics
- 3.3.11. Sustainable materials
- 3.3.12. Robotics and automation
  - 3.3.12.1. Robotic cloud laboratories
  - 3.3.12.2. Automating organism design
  - 3.3.12.3. Artificial intelligence and machine learning
- 3.3.13. Bioinformatics and computational tools
  - 3.3.13.1. Role of Bioinformatics in Synthetic Biology
  - 3.3.13.2. Computational Tools for Design and Analysis
- 3.3.14. Xenobiology and expanded genetic alphabets
- 3.3.15. Biosensors and bioelectronics
- 3.3.16. Feedstocks
  - 3.3.16.1. C1 feedstocks
    - 3.3.16.1.1. Advantages
    - 3.3.16.1.2. Pathways
    - 3.3.16.1.3. Challenges
    - 3.3.16.1.4. Non-methane C1 feedstocks
    - 3.3.16.1.5. Gas fermentation
  - 3.3.16.2. C2 feedstocks
  - 3.3.16.3. Biological conversion of CO2
  - 3.3.16.4. Food processing wastes
  - 3.3.16.5. Lignocellulosic biomass
  - 3.3.16.6. Syngas
  - 3.3.16.7. Glycerol
  - 3.3.16.8. Methane
  - 3.3.16.9. Municipal solid wastes
  - 3.3.16.10. Plastic wastes
  - 3.3.16.11. Plant oils
  - 3.3.16.12. Starch
  - 3.3.16.13. Sugars
  - 3.3.16.14. Used cooking oils
  - 3.3.16.15. Green hydrogen production
  - 3.3.16.16. Blue hydrogen production
- 3.3.17. Marine biotechnology
  - 3.3.17.1. Cyanobacteria
  - 3.3.17.2. Macroalgae
  - 3.3.17.3. Companies

4. MARKET ANALYSIS

4.1. Market trends and drivers
4.2. Industry challenges and constraints
4.3. Synthetic biology in the bioeconomy
4.4. SWOT analysis
4.5. Synthetic biology markets
- 4.5.1. Biofuels
  - 4.5.1.1. Solid Biofuels
  - 4.5.1.2. Liquid Biofuels
  - 4.5.1.3. Gaseous Biofuels
  - 4.5.1.4. Conventional Biofuels
  - 4.5.1.5. Advanced Biofuels
  - 4.5.1.6. Feedstocks
    - 4.5.1.6.1. First-generation (1-G)
    - 4.5.1.6.2. Second-generation (2-G)
      - 4.5.1.6.2.1. Lignocellulosic wastes and residues
      - 4.5.1.6.2.2. Biorefinery lignin
    - 4.5.1.6.3. Third-generation (3-G)
      - 4.5.1.6.3.1. Algal biofuels
        
        4.5.1.6.3.1.1. Properties
        4.5.1.6.3.1.2. Advantages
    - 4.5.1.6.4. Fourth-generation (4-G)
    - 4.5.1.6.5. Energy crops
    - 4.5.1.6.6. Agricultural residues
    - 4.5.1.6.7. Manure, sewage sludge and organic waste
    - 4.5.1.6.8. Forestry and wood waste
    - 4.5.1.6.9. Feedstock costs
  - 4.5.1.7. Synthetic biology approaches for biofuel production
  - 4.5.1.8. Bioethanol
    - 4.5.1.8.1. Ethanol to jet fuel technology
    - 4.5.1.8.2. Methanol from pulp & paper production
    - 4.5.1.8.3. Sulfite spent liquor fermentation
    - 4.5.1.8.4. Gasification
      - 4.5.1.8.4.1. Biomass gasification and syngas fermentation
      - 4.5.1.8.4.2. Biomass gasification and syngas thermochemical conversion
    - 4.5.1.8.5. CO2 capture and alcohol synthesis
    - 4.5.1.8.6. Biomass hydrolysis and fermentation
    - 4.5.1.8.7. Separate hydrolysis and fermentation
      - 4.5.1.8.7.1. Simultaneous saccharification and fermentation (SSF)
      - 4.5.1.8.7.2. Pre-hydrolysis and simultaneous saccharification and fermentation (PSSF)
      - 4.5.1.8.7.3. Simultaneous saccharification and co-fermentation (SSCF)
      - 4.5.1.8.7.4. Direct conversion (consolidated bioprocessing) (CBP)
  - 4.5.1.9. Biodiesel
  - 4.5.1.10. Biogas
    - 4.5.1.10.1. Biomethane
    - 4.5.1.10.2. Feedstocks
    - 4.5.1.10.3. Anaerobic digestion
  - 4.5.1.11. Renewable diesel
  - 4.5.1.12. Biojet fuel
  - 4.5.1.13. Algal biofuels (blue biotech)
    - 4.5.1.13.1. Conversion pathways
    - 4.5.1.13.2. Market challenges
    - 4.5.1.13.3. Prices
    - 4.5.1.13.4. Producers
  - 4.5.1.14. Biohydrogen
    - 4.5.1.14.1. Biological Conversion Routes
      - 4.5.1.14.1.1. Bio-photochemical Reaction
      - 4.5.1.14.1.2. Fermentation and Anaerobic Digestion
  - 4.5.1.15. Biobutanol
  - 4.5.1.16. Bio-based methanol
    - 4.5.1.16.1. Anaerobic digestion
    - 4.5.1.16.2. Biomass gasification
    - 4.5.1.16.3. Power to Methane
  - 4.5.1.17. Bioisoprene
  - 4.5.1.18. Fatty Acid Esters
- 4.5.2. Bio-based chemicals
  - 4.5.2.1. Acetic acid
  - 4.5.2.2. Adipic acid
  - 4.5.2.3. Aldehydes
  - 4.5.2.4. Acrylic acid
  - 4.5.2.5. Bacterial cellulose
  - 4.5.2.6. 1,4-Butanediol (BDO)
  - 4.5.2.7. Bio-DME
  - 4.5.2.8. Dodecanedioic acid (DDDA)
  - 4.5.2.9. Ethylene
  - 4.5.2.10. 3-Hydroxypropionic acid (3-HP)
  - 4.5.2.11. 1,3-Propanediol (1,3-PDO)
  - 4.5.2.12. Itaconic acid
  - 4.5.2.13. Lactic acid (D-LA)
  - 4.5.2.14. 1,5-diaminopentane (DA5)
  - 4.5.2.15. Tetrahydrofuran (THF)
  - 4.5.2.16. Malonic acid
  - 4.5.2.17. Monoethylene glycol (MEG)
  - 4.5.2.18. Propylene
  - 4.5.2.19. Succinic acid (SA)
  - 4.5.2.20. Triglycerides
  - 4.5.2.21. Enzymes
  - 4.5.2.22. Vitamins
  - 4.5.2.23. Antibiotics
- 4.5.3. Bioplastics and Biopolymers
  - 4.5.3.1. Polylactic acid (PLA)
  - 4.5.3.2. PHAs
    - 4.5.3.2.1. Types
      - 4.5.3.2.1.1. PHB
      - 4.5.3.2.1.2. PHBV
    - 4.5.3.2.2. Synthesis and production processes
    - 4.5.3.2.3. Commercially available PHAs
  - 4.5.3.3. Bio-PET
  - 4.5.3.4. Starch blends
  - 4.5.3.5. Protein-based bioplastics
- 4.5.4. Bioremediation
- 4.5.5. Biocatalysis
  - 4.5.5.1. Biotransformations
  - 4.5.5.2. Cascade biocatalysis
  - 4.5.5.3. Co-factor recycling
  - 4.5.5.4. Immobilization
- 4.5.6. Food and Nutraceutical Ingredients
  - 4.5.6.1. Alternative Proteins
  - 4.5.6.2. Natural Sweeteners
  - 4.5.6.3. Natural Flavors and Fragrances
  - 4.5.6.4. Texturants and Thickeners
  - 4.5.6.5. Nutraceuticals and Supplements
- 4.5.7. Sustainable agriculture
  - 4.5.7.1. Crop Improvement and Trait Development
  - 4.5.7.2. Plant-Microbe Interactions and Symbiosis
  - 4.5.7.3. Biofertilizers
    - 4.5.7.3.1. Overview
    - 4.5.7.3.2. Companies
  - 4.5.7.4. Biopesticides
    - 4.5.7.4.1. Overview
    - 4.5.7.4.2. Companies
  - 4.5.7.5. Biostimulants
    - 4.5.7.5.1. Overview
    - 4.5.7.5.2. Companies
  - 4.5.7.6. Crop Biotechnology
    - 4.5.7.6.1. Genetic engineering
    - 4.5.7.6.2. Genome editing
    - 4.5.7.6.3. Companies
- 4.5.8. Textiles
  - 4.5.8.1. Bio-Based Fibers
    - 4.5.8.1.1. Lyocell
    - 4.5.8.1.2. Bacterial cellulose
    - 4.5.8.1.3. Algae textiles
  - 4.5.8.2. Bio-based leather
    - 4.5.8.2.1. Properties of bio-based leathers
      - 4.5.8.2.1.1. Tear strength
      - 4.5.8.2.1.2. Tensile strength
      - 4.5.8.2.1.3. Bally flexing
    - 4.5.8.2.2. Comparison with conventional leathers
    - 4.5.8.2.3. Comparative analysis of bio-based leathers
  - 4.5.8.3. Plant-based leather
    - 4.5.8.3.1. Overview
    - 4.5.8.3.2. Production processes
      - 4.5.8.3.2.1. Feedstocks
      - 4.5.8.3.2.2. Agriculture Residues
      - 4.5.8.3.2.3. Food Processing Waste
      - 4.5.8.3.2.4. Invasive Plants
      - 4.5.8.3.2.5. Culture-Grown Inputs
      - 4.5.8.3.2.6. Textile-Based
      - 4.5.8.3.2.7. Bio-Composite
    - 4.5.8.3.3. Products
    - 4.5.8.3.4. Market players
  - 4.5.8.4. Mycelium leather
    - 4.5.8.4.1. Overview
    - 4.5.8.4.2. Production process
      - 4.5.8.4.2.1. Growth conditions
      - 4.5.8.4.2.2. Tanning Mycelium Leather
      - 4.5.8.4.2.3. Dyeing Mycelium Leather
    - 4.5.8.4.3. Products
    - 4.5.8.4.4. Market players
  - 4.5.8.5. Microbial leather
    - 4.5.8.5.1. Overview
    - 4.5.8.5.2. Production process
    - 4.5.8.5.3. Fermentation conditions
    - 4.5.8.5.4. Harvesting
    - 4.5.8.5.5. Products
    - 4.5.8.5.6. Market players
  - 4.5.8.6. Lab grown leather
    - 4.5.8.6.1. Overview
    - 4.5.8.6.2. Production process
    - 4.5.8.6.3. Products
    - 4.5.8.6.4. Market players
  - 4.5.8.7. Protein-based leather
    - 4.5.8.7.1. Overview
    - 4.5.8.7.2. Production process
    - 4.5.8.7.3. Commercial activity
  - 4.5.8.8. Recombinant Materials
  - 4.5.8.9. Sustainable Processing
- 4.5.9. Packaging
  - 4.5.9.1. Polyhydroxyalkanoates (PHA)
  - 4.5.9.2. Applications
    - 4.5.9.2.1. Vials, bottles, and containers
    - 4.5.9.2.2. Disposable items and household goods
    - 4.5.9.2.3. Food packaging
    - 4.5.9.2.4. Wet wipes and diapers
  - 4.5.9.3. Proteins
  - 4.5.9.4. Algae-based
  - 4.5.9.5. Mycelium
  - 4.5.9.6. Antimicrobial films and agents
- 4.5.10. Healthcare and Pharmaceuticals
  - 4.5.10.1. Drug discovery and development
  - 4.5.10.2. Gene therapy and regenerative medicine
  - 4.5.10.3. Vaccine production
  - 4.5.10.4. Personalized medicine
  - 4.5.10.5. Diagnostic tools and biosensors
  - 4.5.10.6. Companies
- 4.5.11. Cosmetics
- 4.5.12. Surfactants and detergents
- 4.5.13. Construction materials
  - 4.5.13.1. Bioconcrete
  - 4.5.13.2. Microalgae biocement
  - 4.5.13.3. Mycelium materials
4.6. Global market revenues 2018-2036
- 4.6.1. By Technology
- 4.6.2. By Product Type
- 4.6.3. By Market
- 4.6.4. By Region
4.7. Future Market Outlook

5. COMPANY PROFILES (321 company profiles)

6. APPENDIX

6.1. Research Methodology
6.2. Glossary of Terms

合成生物学（シンバイオ）の世界市場（2026年～2036年）

The Global Synthetic Biology (SynBio) Market 2026-2036

目次

第1章エグゼクティブサマリー

第2章イントロダクション

第3章技術分析

第4章市場の分析

第5章企業プロファイル（企業321社のプロファイル）

第6章付録

第7章参考文献

List of Tables

List of Figures

Report contents include:

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. INTRODUCTION

3. TECHNOLOGY ANALYSIS

4. MARKET ANALYSIS

5. COMPANY PROFILES (321 company profiles)

6. APPENDIX

7. REFERENCES

合成生物学（シンバイオ）の世界市場（2026年～2036年）

The Global Synthetic Biology (SynBio) Market 2026-2036

目次

第1章 エグゼクティブサマリー

第2章 イントロダクション

第3章 技術分析

第4章 市場の分析

第5章 企業プロファイル（企業321社のプロファイル）

第6章 付録

第7章 参考文献

List of Tables

List of Figures

Report contents include:

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. INTRODUCTION

3. TECHNOLOGY ANALYSIS

4. MARKET ANALYSIS

5. COMPANY PROFILES (321 company profiles)

6. APPENDIX

7. REFERENCES

第1章エグゼクティブサマリー

第2章イントロダクション

第3章技術分析

第4章市場の分析

第5章企業プロファイル（企業321社のプロファイル）

第6章付録

第7章参考文献